Legal Implications of Peptide Use in Sports

Introduction

The legal status of peptides in sports varies by country and by sport. For competitive athletes, anti-doping rules usually matter more than drug law: a positive test can end a career even where possession is legal.

WADA Prohibited List

Status of Common Peptides

As of October 2026, WADA's 2026 Prohibited List is in force. It prohibits these peptides in and out of competition:

BPC-157, named under S0 (non-approved substances)
TB-500 and thymosin beta-4, named under S2.3 (growth factors), not S0
GH secretagogues such as ipamorelin (S2.2.4); that section also covers GHRPs and GHRH analogs
IGF-1 and its analogues (S2.3) and myostatin inhibitors (S4.3)

WADA has published the 2027 List, which takes effect January 1, 2027. Its S0 definition now adds peptides to the examples of non-approved substances. USADA warns that a peptide not named on the list may still be prohibited.

Detection Methods

Blood and urine testing
Athlete Biological Passport
Out-of-competition testing

Penalties

Under the World Anti-Doping Code, athletes are strictly liable for whatever is in their system.

Competition bans (2-4 years typical)
Stripping of results
Financial consequences

National Laws

Outside sport, the rules depend on the country; our page on legal and ethical considerations covers them. In April 2026, an Australian TGA safety alert and a Health Canada advisory both named BPC-157 and TB-500. Both say a "research use only" label does not make these products legal to supply.

Sport-Specific Regulations

Natural Bodybuilding Federations

The legal side of peptides in bodybuilding has its own page.

Untested Divisions

No prohibition in some federations
Still subject to national laws

Other Sports

Sports bound by the World Anti-Doping Code follow the WADA list
College sports (NCAA) have own testing

For a section-by-section breakdown, see the status of peptides in competitive sports.

Legal Risks

For Athletes

Career-ending sanctions
Legal prosecution (varies by country)
Loss of sponsorships

Compliance Strategies

For tested athletes:

Verify status of all supplements
Consider therapeutic use exemptions where applicable

USADA notes that its Global DRO lookup does not list every prohibited peptide.

What to watch next

WADA has not named elamipretide (SS-31) or bremelanotide (PT-141), which are now approved prescription medicines, so their status is unclear as of October 2026.